FDA clears Pfizer COVID-19 vaccine boosters for vulnerable groups

Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images The Food and Drug Administration cleared a third dose of the Pfizer / BioNTech COVID-19 vaccine for people some vulnerable groups — the first booster in the United States’ vaccination efforts. The agency signed off on boosters for people 65 years of age and older, those who are at high risk of severe disease, health care workers, and other people at high risk of exposure to COVID-19 at work. The decision comes a month after the Biden administration announced that booster shots would be available to people in the US starting in September. At the time, scientists and public health experts criticized the administration for pushing boosters before there was clear evidence that they were necessary and before either the FDA or CDC signed off... Continue reading…

FDA clears Pfizer COVID-19 vaccine boosters for vulnerable groups
Vials of the Pfizer COVID-19 vaccine are seen at a...
Photo by Paul Hennessy/SOPA Images/LightRocket via Getty Images

The Food and Drug Administration cleared a third dose of the Pfizer / BioNTech COVID-19 vaccine for people some vulnerable groups — the first booster in the United States’ vaccination efforts.

The agency signed off on boosters for people 65 years of age and older, those who are at high risk of severe disease, health care workers, and other people at high risk of exposure to COVID-19 at work.

The decision comes a month after the Biden administration announced that booster shots would be available to people in the US starting in September. At the time, scientists and public health experts criticized the administration for pushing boosters before there was clear evidence that they were necessary and before either the FDA or CDC signed off...

Continue reading…